ALNYLAM PHARMACEUTICALS, INC. |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 228 EUR | -0.09% |
|
-0.87% | +28.93% |
| 07-03 | Jerome Powell did it again |  |
| 07-03 | JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | -0.09% | -0.87% | - | - | - | 31.46B | - | - | - |
